Banik Debasis, Hamidinia Maryam, Brzostek Joanna, Wu Ling, Stephens Hannah M, MacAry Paul A, Reinherz Ellis L, Gascoigne Nicholas R J, Lang Matthew J
Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
Translational Immunology Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
J Phys Chem Lett. 2021 Aug 12;12(31):7566-7573. doi: 10.1021/acs.jpclett.1c02240. Epub 2021 Aug 4.
Chimeric antigen receptor (CAR) T-cell therapies exploit facile antibody-mediated targeting to elicit useful immune responses in patients. This work directly compares binding profiles of CAR and αβ T-cell receptors (TCR) with single cell and single molecule optical trap measurements against a shared ligand. DNA-tethered measurements of peptide-major histocompatibility complex (pMHC) ligand interaction in both CAR and TCR exhibit catch bonds with specific peptide agonist peaking at 25 and 14 pN, respectively. While a conformational transition is regularly seen in TCR-pMHC systems, that of CAR-pMHC systems is dissimilar, being infrequent, of lower magnitude, and irreversible. Slip bonds are observed with CD19-specific CAR T-cells and with a monoclonal antibody mapping to the MHC α2 helix but indifferent to the bound peptide. Collectively, these findings suggest that the CAR-pMHC interface underpins the CAR catch bond response to pMHC ligands in contradistinction to slip bonds for CARs targeting canonical ligands.
嵌合抗原受体(CAR)T细胞疗法利用简便的抗体介导靶向作用,在患者体内引发有效的免疫反应。这项研究通过单细胞和单分子光镊测量,直接比较了CAR和αβT细胞受体(TCR)与共同配体的结合情况。对CAR和TCR中肽-主要组织相容性复合体(pMHC)配体相互作用的DNA连接测量显示,与特定肽激动剂的捕获键分别在25 pN和14 pN达到峰值。虽然在TCR-pMHC系统中经常观察到构象转变,但CAR-pMHC系统的构象转变不同,频率较低、幅度较小且不可逆。在CD19特异性CAR T细胞以及与MHC α2螺旋结合但对结合肽无反应的单克隆抗体中观察到滑动键。总体而言,这些发现表明,与靶向经典配体的CAR的滑动键不同,CAR-pMHC界面是CAR对pMHC配体捕获键反应的基础。